Pharmacogenomics and public health
- PMID: 19204414
- PMCID: PMC2836943
- DOI: 10.1159/000189624
Pharmacogenomics and public health
References
-
- Carlson RJ. The disruptive nature of personalized medicine technologies: implications for the health care system. Public Health Genomics. 2009;12:180–184. - PubMed
-
- Garrison LP. Will pharmacogenomics disrupt the US health care system? No. Public Health Genomics. 2009;12:185–190. - PubMed
-
- Lee SSJ. Pharmacogenomics and the challenge of health disparities. Public Health Genomics. 2009;12:170–179. - PubMed
-
- Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE, Jr, Wickerham DL, Wolmark N. Gene expression and benefit of chemotherapy in women with nodenegative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3726–3734. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources